XTX Topco’s ESSA Pharma EPIX Stock Holding History

XTX Topco’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,524	Closed	-$8.7K	–	3435
2025 Q3	$8.7K	Buy	45,524 +3,351	+8%	+$4.01K	﹤0.01%	2450
2025 Q2	$71.7K	Buy	42,173 +19,344	+85%	+$32.6K	﹤0.01%	1948
2025 Q1	$36.1K	Sell	22,829 -14,697	-39%	-$24.9K	﹤0.01%	2045
2024 Q4	$67.2K	Buy	+37,526	New	+$120K	0.01%	1846
2022 Q4	–	Sell	-23,338	Closed	-$42K	–	1229
2022 Q3	$42K	Buy	+23,338	New	+$61.5K	0.01%	1037

XTX Topco's EPIX Position: Q4 2025 in Review

XTX Topco sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 45,524 shares — an estimated $8.7K sold.

XTX Topco first reported a position in EPIX in Q3 2022 and held it in 5 quarters. The position peaked at $71.7K in Q2 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

XTX Topco reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 45,524 ESSA Pharma shares in Q4 2025, an estimated $8.7K.
XTX Topco first reported a position in ESSA Pharma in Q3 2022 and held it in 5 quarters.
XTX Topco's ESSA Pharma position peaked at $71.7K in Q2 2025.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.